0001596494-17-000002.txt : 20170608 0001596494-17-000002.hdr.sgml : 20170608 20170608092533 ACCESSION NUMBER: 0001596494-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170608 DATE AS OF CHANGE: 20170608 EFFECTIVENESS DATE: 20170608 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ralexar Therapeutics, Inc. CENTRAL INDEX KEY: 0001596494 IRS NUMBER: 463970052 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-288286 FILM NUMBER: 17899200 BUSINESS ADDRESS: STREET 1: 101 LINDENWOOD DRIVE STREET 2: SUITE 400 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-318-2988 MAIL ADDRESS: STREET 1: 101 LINDENWOOD DRIVE STREET 2: SUITE 400 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Alexar Therapeutics, Inc. DATE OF NAME CHANGE: 20140110 D 1 primary_doc.xml X0707 D LIVE 0001596494 Ralexar Therapeutics, Inc. 101 LINDENWOOD DRIVE SUITE 400 MALVERN PA PENNSYLVANIA 19355 484-318-2988 DELAWARE Alexar Therapeutics, Inc. Corporation true 2013 David Pfeiffer 101 Lindenwood Drive Suite 400 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Douglas Gessl 101 Lindenwood Drive Suite 400 Malvern PA PENNSYLVANIA 19355 Executive Officer Somu Subramaniam 610 Fifth Avenue 3rd Floor New York NY NEW YORK 10020 Director Jason Hong 2180 Sand Hill Road Suite 400 Menlo Park CA CALIFORNIA 94025 Director Stephen Tullman 101 Lindenwood Drive Suite 400 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Neal Walker 101 Lindenwood Drive Suite 400 Malvern PA PENNSYLVANIA 19355 Director Pharmaceuticals Decline to Disclose 06b false 2017-05-31 false true false 2900 6908638 4145191 2763447 false 26 0 0 600000 true false Ralexar Therapeutics, Inc. David Pfeiffer David Pfeiffer Chief Executive Officer 2017-06-06